PT  - JOURNAL ARTICLE
AU  - Alexis Boneparth
AU  - Suhas M. Radhakrishna
AU  - Larry A. Greenbaum
AU  - Eric Yen
AU  - Daryl M. Okamura
AU  - Jennifer C. Cooper
AU  - Sherene Mason
AU  - Deborah M. Levy
AU  - Sangeeta D. Sule
AU  - Paul T. Jensen
AU  - Cagri Yildirim-Toruner
AU  - Stacy P. Ardoin
AU  - Scott E. Wenderfer
TI  - Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists
AID  - 10.3899/jrheum.170502
DP  - 2017 Nov 01
TA  - The Journal of Rheumatology
PG  - 1619--1623
VI  - 44
IP  - 11
4099  - http://www.jrheum.org/content/44/11/1619.short
4100  - http://www.jrheum.org/content/44/11/1619.full
SO  - J Rheumatol2017 Nov 01; 44
AB  - Objective. To describe treatment practices for childhood pure membranous lupus nephritis (MLN).Methods. Survey study of Childhood Arthritis and Rheumatology Research Alliance and American Society of Pediatric Nephrology members.Results. There were 117 respondents who completed the survey (60 pediatric nephrologists, 57 pediatric rheumatologists). Steroids and nonsteroid immunosuppression (NSI) were routinely used by the majority for MLN. Mycophenolate mofetil was the favored initial NSI. Nephrologists used steroids (60% vs 93%) and NSI (53% vs 87%) less often than did rheumatologists for MLN without nephrotic syndrome (NS).Conclusion. Pediatric rheumatologists and nephrologists both recommend steroids and NSI for children with MLN, with or without NS.